The effectiveness and possible side-effects of a new drug are extensively studied in the early pre-clinical phase, long before it becomes available in the market. InnoSer provides knowledge and research possibilities to universities, public research institutions and biomedical and pharmaceutical companies.<\/p>\n
Proof of concept<\/strong> Effects in the body<\/strong> In vitro en in vivo<\/strong> The effectiveness and potential side effects of a new drug are already extensively studied in the early preclinical phase, well before it becomes available on the market.<\/p>","protected":false},"featured_media":1820,"parent":0,"template":"","soort-investeringen":[62],"land":[56],"class_list":["post-1288","portfolio","type-portfolio","status-publish","has-post-thumbnail","hentry","soort-investeringen-historische-investeringen","land-belgie"],"yoast_head":"\n
\nTo test, check the dosage and determine any side-effects of a potential new drug, studies are already undertaken in an early phase of the development. In the proof of concept phase InnoSer supports the developers with research and advice.<\/p>\n
\nDuring the studies, the experts examine what happens to a substance when it enters the body: from the moment of intake to the moment the substance completely disappears from the body. Pharmacodynamic studies investigate the effects of the substance on the body (the efficacy as medication). InnoSer focuses particularly, although not exclusively, on studies for immunological, oncological or renal disorders.<\/p>\n
\nInnoSer\u2019s specialist laboratories always have the right climatic conditions and expertise at their disposal. Studies are performed using test-tube methods (in vitro) and, where this is not possible, laboratory animals (in vivo). The rooms and methods adhere to the strictest statutory quality requirements. The highly experienced InnoSer specialists can advise on the best formulations and dosages for the optimum result.<\/p>","protected":false},"excerpt":{"rendered":"